Sinopharm’s inactivated vaccine is China’s first domestic COVID-19 vaccine On the last day of 2020, the Joint Prevention and Control Mechanism of State Council announced that China National Pharmaceutical Group’s (AKA Sinopharm) inactivated COVID-19 vaccine obtained conditional marketing approval, a fast-tracked authorization process for treatments that...

Request ESG Software Demo

Email must be formatted correctly
Thank you for your interest in Seneca ESG. We will be in contact shortly.
Contact Us